Cellex-C's 'Ring The Bell' Cancer Challenge
John Chilver, the President and CEO of Cellex-C International Inc. and his friend Geoff Stark, a retired police officer, are going to be riding the iconic climbs of the Tour defence in the French Alps and Pyrenees in aid of the Canadian Cancer Society. John Chilver, the President and CEO of Cellex-C International Inc. and his friend Geoff Stark, a retired police officer, are going to be riding the iconic climbs of the Tour de France in the French Alps and Pyrenees in aid of the Canadian Cancer Society.
Starting at $1,000 and adding $500 for every col they successfully climb, Cellex-C International is going to make a donation to the battle against cancer. That means that if they manage to conquer ten mountains on this trip, by the last one, Cellex-C will be donating $5,500 and a grand total of $32,500 to the Canadian Cancer Society.
In many hospitals around the world, whenever a cancer patient successfully completes a course of chemo, he or she rings a bell, and that's what John and Geoff are planning to do in their honour at the top of every col they climb.
Fighting cancer also means a lot to John and Geoff on a personal level. John's sister, the founder of Cellex-C International, passed away three years ago from a rare form of intestinal cancer, followed a few months later by his father who died from lung cancer after decades of smoking. Geoff's dad was also killed by lung cancer, again, from that most lethal pastime.
Their ride is for everyone who has battled cancer, or is currently in that fight.
Let’s conquer this terrible disease. For good. Let's ring that bell. For the last time.
Follow John and Geoff's assault on the mountains - and cancer- on the Cellex-C website http://www.cellex-c.com/challenge.php
They should be starting their ride on July 31st, but you can begin helping now by donating below.
See you at the summit!
About the Canadian Cancer Society
The Canadian Cancer Society is a national, community-based organization of volunteers whose mission is the eradication of cancer and the enhancement of the quality of life of people living with cancer. For more information, visit www.cancer.ca.
If you think this page contains objectionable content, please inform the system administrator.